Browsing Tag

Donanemab

Eli Lilly expects FDA decision on Alzheimer’s treatment donanemab by the end of the year

Jason Junior Jul 17, 2023

Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain.Cristina Arias | Cover | Getty ImagesEli Lilly on Monday said it applied for full U.S. Food and Drug Administration approval of its Alzheimer's…

Health

Eli Lilly Alzheimer’s treatment donanemab slowed disease progression in clinical trial

Jason Junior May 3, 2023

An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021.Mike Segar | ReutersThe Alzheimer's treatment donanemab, which is made by Eli Lilly, significantly slowed…

Health

Alzheimer’s Donanemab; Treating Long COVID Fatigue; Newer Epilepsy Drugs and Suicide

Jason Junior Aug 11, 2021

Eli Lilly plans to seek FDA approval for donanemab, its investigational Alzheimer's drug that cleared amyloid plaques and slowed cognitive…